Cambridge, UK – 16 October 2024 – The Cambridge Crystallographic Data Centre (CCDC) announces two significant scientific papers detailing the findings of the 7th Crystal Structure Prediction (CSP) Blind Test. To coincide with the publication of the two papers, the CCDC has released a CSP Blind Test database that contains 171,679 entries from 207 landscapes.

Expanding CSP Beyond Pharmaceuticals

Glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management, Dexcom, and pharmaceutical and medical devices organisation, Abbott, have been locked in a series of patent disputes over their continuous glucose monitoring (CGM) devices and systems, in a battle that spans multiple patents and several jurisdictions including the UK, US and Germany. In the UK alone, both parties have brough infringement proceedings, with a total of seventeen patents being at issue.

In January 2024 Cameroon launched the world’s first routine malaria vaccine programme. By incorporating the RTS,S vaccine into its standard immunisation schedule, Cameroon aims to protect thousands of children across Africa and significantly reduce malaria-related fatalities.

Closely following suit, the Côte d’Ivoire has recently become the first country to roll-out the new R21/Matrix-M™ vaccine, in another key advancement in the battle against malaria.

• Series C round led by Elevage Medical Technologies
• Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally

Pioneer Group, the specialist life science infrastructure and venture-building company, welcomed 425 school children from 29 schools to eight of its sites across the UK this week to mark Ada Lovelace Day, an international celebration of the achievements of women in STEM.

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function, Focus area, Location

BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.